Global Hematology Diagnostics Market Size to Surge At 5.8% CAGR Over 2020-2025

January 12, 2021


As per the intelligence report titled ‘Global Hematology Diagnostics Market Analysis, 2020’, available with Market Study Report LLC, global hematology diagnostics market is estimated to record a y-o-y growth rate of 5.8% through 2025.
 

Increasing instances of blood related disorders such as thalassemia and leukemia in all age brackets, alongside booming elderly population who are susceptible to health ailments are propelling the growth of global hematology diagnostics market. According to Leukemia & Lymphoma Society, 174,250 new cases of myeloma, lymphoma, and leukemia were recorded in the United States in 2018, of which majority affected were below 20 years of age.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3114651/
 

Technological advancements such as automated testers & analyzers, along with collective preference for instruments with high & efficient output, and adoption of flow cytometers are stimulating global hematology diagnostics industry trends.
 

On the downside, limited cognizance of blood disorders, scarce availability and high cost of instruments, in consort with poor health insurance coverage are arresting the worldwide hematology diagnostics market remuneration.
 

As per product terrain, the market is classified into flow cytometers, semi-automated hematology analyzer, fully-automated hematology analyzer, hematology instruments, hematology analyzer, and others.
 

Based on consumable gamut, global hematology diagnostics market is segmented into controls & calibrations, stains, reagents, and others. While the end-user scope included commercial service providers, academic institutes, diagnostic laboratories, hospitals & clinics, and others.
 

From regional frame of reference, North America is slated to emerge as lucrative growth avenue for global hematology diagnostics industry partakers over the forthcoming years, owing to rising pervasiveness of blood disorders. According to Centers for Disease Control & Prevention,
approximately 70,000 to 100,000 individuals were suffering from sickle cell ailment in the United States in 2019. Besides, the healthcare facilities in the region are well-equipped with automated technology, hence positively swaying the business dynamics.
 

Companies which are profiled in global hematology diagnostics market report are F. Hoffmann-La Roche AG, Danaher Corp., Nihon Kohden Corp., Sysmex Corp., Horiba Ltd., BioRad Laboratories Inc., BioSystems S.A., Siemens Healthineers AG, Mindray Medical International Ltd., and Abbott Laboratories.

Chat with us